NRD
RGEN icon

Nebula Research & Development’s Repligen RGEN Stock Holding History

Nebula Research & Development’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,603
Closed -$685K – 1075
2024
Q3 		$685K Buy
+4,603
New +$660K 0.08% 450
2024
Q1 		– Sell
-3,618
Closed -$651K – 952
2023
Q4 		$651K Buy
3,618
+1,505
+71% +$234K 0.2% 164
2023
Q3 		$336K Buy
+2,113
New +$345K 0.18% 241

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Nebula Research & Development's RGEN Position: Q4 2024 in Review

Nebula Research & Development sold out of Repligen (RGEN) in Q4 2024, closing a stake of 4,603 shares — an estimated $685K sold.

Nebula Research & Development first reported a position in RGEN in Q3 2023 and held it in 3 quarters. The position peaked at $685K in Q3 2024. 431 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.

  • Nebula Research & Development reported no remaining Repligen position as of Q4 2024 after selling out during the quarter.
  • Nebula Research & Development sold 4,603 Repligen shares in Q4 2024, an estimated $685K.
  • Nebula Research & Development first reported a position in Repligen in Q3 2023 and held it in 3 quarters.
  • Nebula Research & Development's Repligen position peaked at $685K in Q3 2024.
  • 431 funds tracked by Wall St. Rank held Repligen as of Q4 2024.

Based on Nebula Research & Development's 13F filing for Q4 2024, filed 14 Feb 2025.